GFAP and Stroke: However, post-hoc comparisons analyses only reported significantly reduced GFAP+ve expression in the IL region of animals treated with combined compound G + rhBDNF (171,345 ± 35,220) when compared to stroke animals treated with rhBDNF alone (270,829 ± 44,829; p = 0.0067).